HUVECs |
Apoptosis Assay |
10 μM |
24 h |
bolishes the protective effect of resveratrol in cell viability |
23358928 |
RMECs |
Apoptosis Assay |
10 μM |
24 h |
attenuates the anti-apoptotic effect of Des-G |
24486147 |
Platelets |
Apoptosis Assay |
10/50 μM |
10 min |
increases ROS level in a dose-dependent manner |
25829495 |
K562 |
Function Assay |
0.1-1 μM |
2 h |
stimulates Nrf2-dependent gene transcription |
21196497 |
INS-1E |
Function Assay |
1 μm |
24 h |
prevents resveratrol-induced up-regulation of Glut2, glucokinase,Pdx-1, and Tfam |
21163946 |
MCF-7 |
Growth Inhibition Assay |
0-100 μM |
24/48/72 h |
represses cell proliferation at the concentration ≥100 μM |
20371709 |
NCI-H460 |
Function Assay |
1 μm |
6 h |
produces a concentration-dependent increase in the amount of acetylated p53 |
16354677 |
HCT116 |
Function assay |
10 uM |
8 hrs |
Inhibition of SIRT1 in human HCT116 cells assessed as increase in acetylated p53 at 10 uM after 8 hrs by Western blot analysis |
22642300 |
HeLa |
Growth Inhibition Assay |
|
48 h |
IC50=8.9 ± 1.9 μM |
24998427 |
HEK 293 |
Growth Inhibition Assay |
|
48 h |
IC50=69.0 ± 0.7 μM |
24998427 |
HeLa |
Growth Inhibition Assay |
|
24 h |
IC50=37.9 ± 1.8 μM |
24998427 |
HEK 293 |
Growth Inhibition Assay |
|
24 h |
IC50=97.7 ± 8.1 μM |
24998427 |
Namalwa cells |
Function assay |
|
3 hrs |
Inhibition of SIRT1-mediated endogenous p53 deacetylase activity in human Namalwa cells assessed as concentration required to enhance p53 deacetylation to twice the basal level after 3 hrs by ELISA, INH = 0.6 μM. |
25971769 |
Hs683 |
Cell cycle assay |
|
24 to 48 hrs |
Cell cycle arrest in human Hs683 cells assessed as accumulation at G1 phase at IC50 after 24 to 48 hrs by propidium iodide staining-based flow cytometry |
28475330 |
NCI-H460 |
Function assay |
|
6 hrs |
Inhibition of SIRT-2 in human NCI-H460 cells assessed as inhibition of p53 deacetylation after 6 hrs by immunoprecipitation/immunoblotting analysis, IC50 = 1 μM. |
ChEMBL |
293T |
Function assay |
|
|
Inhibition of human recombinant GST-tagged SIRT1 expressed in 293T cells by Fluor de Lys fluorescence assay, IC50 = 0.038 μM. |
21306906 |
Escherichia coli cells |
Function assay |
|
|
Inhibition of human recombinant SIRT1 expressed in Escherichia coli cells using acetylated Lys side chain amino acids 379-382 (Arg-His-Lys-Lys(Ac)) p53 conjugated with aminomethylcoumarin as substrate by fluorescence assay, IC50 = 0.16 μM. |
22931526 |
BL21 (DE3) |
Function assay |
|
|
Inhibition of full length human SIRT1 expressed in Escherichia coli BL21 (DE3) cells using fluorogenic 7-amino-4-methylcoumarin (AMC)-labeled peptide by fluorescence assay, IC50 = 0.21 μM. |
25275824 |
BL21 (DE3) |
Function assay |
|
|
Inhibition of full length human SIRT2 expressed in Escherichia coli BL21 (DE3) cells using fluorogenic 7-amino-4-methylcoumarin (AMC)-labeled peptide by fluorescence assay, IC50 = 1.94 μM. |
25275824 |
Escherichia coli cells |
Function assay |
|
|
Inhibition of human recombinant SIRT2 expressed in Escherichia coli cells using acetylated Lys side chain amino acids 379-382 (Arg-His-Lys-Lys(Ac)) p53 conjugated with aminomethylcoumarin as substrate by fluorescence assay, IC50 = 48.5 μM. |
22931526 |
A673 |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells |
29435139 |
SK-N-MC |
qHTS assay |
|
|
qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells |
29435139 |